Medacta Group SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medacta Group SA (MOVE)
Track today's live Medacta (MOVE) share price, performance and key data on this page with our current Switzerland:MOVE stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Medacta share price on the Switzerland exchange. Use the dropdown to switch exchange for the MOVE share price, head to our technical summary section, which provides analysis on Medacta share price buy/sell indicators using real-time data (or discuss the Medacta (MOVE) stock price today with other investors in the Medacta SIX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SIX:MOVE share price (ISIN: CH0468525222) to enhance your trading decisions with our free investment tools and resources.
What Is the Medacta Group SA Share Price Today?
The Medacta share price today is 114.60.
What Is the Stock Symbol for Medacta Group SA
The stock symbol (or 'ticker') for Medacta Group SA is "MOVE."
What Stock Exchange Does Medacta Group SA Trade On?
Medacta Group SA is listed and trades on the Switzerland stock exchange.
Is Medacta Group SA a Good Stock to Buy?
Determining whether Medacta (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current SIX:MOVE share price (ISIN: CH0468525222) to enhance your trading decisions with our free investment tools and resources.
What Is the Medacta Group SA Share Price Today?
The Medacta share price today is 114.60.
What Is the Stock Symbol for Medacta Group SA
The stock symbol (or 'ticker') for Medacta Group SA is "MOVE."
What Stock Exchange Does Medacta Group SA Trade On?
Medacta Group SA is listed and trades on the Switzerland stock exchange.
Is Medacta Group SA a Good Stock to Buy?
Determining whether Medacta (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
114.60
+1.20(+1.06%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
113.00
115.60
52 wk Range
107.40
177.20
MOVE is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
113.00115.60
52 wk Range
107.40177.20
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.97%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.97%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MOVE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
159.78
Upside
+39.42%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Medacta Group SA receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Medacta Group SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Medacta Group SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 159.78
(+39.42% Upside)
Medacta Group SA Earnings Call Summary for H1/2026
- Medacta reported H1 2026 revenue of EUR 368M, up 10% in constant currency, with adjusted EBITDA margin at 27.8% but shares fell 3.43%.
- Gross margin declined 310 basis points to 65.2% due to FX headwinds and pricing pressure; free cash flow turned negative at EUR 18.6M.
- Company reaffirmed full-year guidance of 10-14% constant-currency revenue growth and 50 basis point EBITDA margin expansion versus 2025.
- Management expects H2 improvement driven by U.S. recovery, India knee product launch in September, and easier European comparisons.
- CEO noted H1 was weakest semester in five years, citing U.S. market normalization to 3% growth and customer shifts to ambulatory surgery centers.
Last Updated: 09/09/2026, 15:08
Read Full TranscriptEarnings
Latest Release
09/09/2026
EPS / Forecast
2.10 / --
Revenue / Forecast
368.17M / --
Compare MOVE to Peers and Sector
Metrics to compare | MOVE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMOVEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 31.4x | 18.9x | −0.3x | |
PEG Ratio | −1.70 | 0.34 | 0.00 | |
Price/Book | 5.0x | 1.5x | 2.6x | |
Price / LTM Sales | 3.4x | 1.3x | 3.0x | |
Upside (Analyst Target) | 39.5% | 34.5% | 58.5% | |
Fair Value Upside | Unlock | 22.7% | 7.1% | Unlock |
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Medacta (Switzerland: MOVE) Share Price Today?
The Medacta stock price today is 114.60 CHF.
What Stock Exchange Does Medacta (MOVE) Trade On?
Medacta is listed and trades on the Switzerland Stock Exchange.
What Is the Ticker (Stock Symbol) for Medacta?
The stock symbol (also called a 'ticker') for Medacta is "MOVE."
Does Medacta Pay Dividends? What’s The Current MOVE Dividend Yield?
Yes, MOVE Pays Dividends to its Shareholders. The current Medacta dividend yield is 0.97%.
What Is the Current Medacta Market Capitalisation?
As of today, Medacta (Switzerland: MOVE) market cap is 2.29B CHF.
What Is Medacta's (MOVE) Earnings Per Share (TTM)?
The Medacta EPS is currently 3.87 (Trailing Twelve Months).
Is MOVE a Buy or Sell From a Technical Analyst Perspective?
Based on today's Medacta moving averages and other technical indicators, the daily buy/sell signal for MOVE stock is Strong Sell.
How Many Times Has Medacta Stock Split?
Medacta has split 0 times. (See the MOVE stock split history page for full effective split date and price information.)
How Many Employees Does Medacta Have?
Medacta has 2273 employees, based on their latest Companies House report.
What is the current trading status of Medacta (Switzerland: MOVE)?
As of 06/10/2026, Medacta (MOVE) is trading at a share price of 114.60 CHF, with a previous close of 114.60 CHF. The stock has fluctuated within a day range of 113.00 CHF to 115.60 CHF, while its 52-week range spans from 107.40 CHF to 177.20 CHF.
What Is Medacta (MOVE) Price Target According to Analysts?
The average 12-month price target for Medacta is 159.78 CHF, with a high estimate of 189.41941477 CHF and a low estimate of 119.10636321 CHF. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +39.42% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.